|该报告包含COVID-19specific updates.
阿尔茨海默氏病治疗和诊断：全球市场
Report Highlights
阿尔茨海默氏病治疗的全球市场应从2020年的48亿美元增长到2025年的63亿美元，在2020 - 2025年期间的复合年增长率（CAGR）为5.5％。
Report Includes
- 27个桌子
- 阿尔茨海默氏病全球市场（AD）治疗和诊断概述
- Estimation of the market size and analyses of global market trends with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- 阿尔茨海默氏病以及有关疾病相关事件，病因和流行病学的详细说明涵盖了患病率和发病率
- 识别诊断工具和设备；评估重要的科学和技术框架；以及阿尔茨海默氏病治疗和诊断的全球市场发展中的发展。
- Information on products that are currently available for the diagnosis and treatment of Alzheimer's disease as well as highlights of the promising new drug candidates and diagnostic imaging agents
- Market share analysis of Alzheimer's disease therapeutics and diagnostics, by mechanism of action, disease stage and major geographical regions covering North America, Europe, APAC and Rest of the World
- 详细分析当前市场趋势，市场预测，驱动因素，挑战以及影响市场增长的机会以及对影响未来市场的监管和竞争性要素的讨论
- 对行业主要公司的市场份额分析以及合并和收购，合资，合作或合作伙伴关系以及其他关键市场策略等活动的覆盖范围
- Company profiles of major market players, including AbbVie, AstraZeneca Plc, Bristol-Myers Squibb, Eli Lilly and Co., F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Pfizer Inc., Novartis and Sanofi
报告范围
这项研究的范围涵盖了阿尔茨海默氏症治疗和诊断的全球和区域市场。这些市场通过品牌和仿制药，以及作用机制（例如乙酰胆碱抑制剂（ACHEI）和N-甲基-D-天冬氨酸（NMDA）受体拮抗剂，氧化甲氧甲便和多甲甲苯和美洲甲酸酯的组合，TAU聚集抑制剂（TAI）的组合，和淀粉样β（Aβ）疫苗。药物还通过他们治疗的阿尔茨海默氏病的阶段（即轻度至中度，严重和前驱物）进行了细分。
乐动体育-西甲2019赞助商BCC研究分析了每个市场及其应用，监管环境，辅助技术，市场预测和市场份额。讨论的问题包括主要的药物概况，临床基础，技术特征和趋势。广告疗法和诊断的区域市场包括美国，加拿大，英国，法国，德国，意大利，西班牙，日本，中国和印度的选定市场。这些市场被分组为北美，欧洲，亚太地区和世界其他地区（行）。
分析师证书
BCC出版Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.
Report Highlights
The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.
Report Includes
- An overview of the global market for Alzheimer's disease therapeutic and diagnostic technologies
- 全球市场趋势的分析，从2014年开始的数据，2015年的估计以及复合年增长率（CAGR）至2020年的预测
- Review of programs in development and quantification of market opportunities
- 讨论市场细分市场的经济环境，技术描述和问题以及应用
- Projections of usage in the major primary and secondary disease application areas
- 业内主要参与者的个人资料
Report Highlights
The global market for alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%.
Report Includes
- An overview of the global market for Alzheimer's disease therapeutic and diagnostic technologies
- 对全球市场趋势的分析，以及2011年和2012年的数据，以及2017年复合年增长率（复合年增长率）的预测
- Review of programs in development and quantification of market opportunities
- 讨论市场细分市场的经济环境，技术描述和问题以及应用
- Projections of usage in the major primary and secondary disease application areas
- Comprehensive company profiles of major players in the industry.
Report Highlights
-
总体而言，对阿尔茨海默氏病的预测，包括调整疾病的治疗剂，治疗相关症状的治疗剂，诊断和成像，将增加 指数。该市场在2009年价值80亿美元，预计到2014年将达到96亿美元，复合年增长率（CAGR）为3.7％。
-
预计诊断和生物标志物将在5年化合物中增加 growth rate (CAGR) of nearly 20%. This segment was worth $1.2 billion in 2009 and is expected to reach $2.9 billion by 2014.
-
成像行业在2009年价值3.61亿美元，预计将以近19％的复合年增长率（CAGR）增长，达到2014年的8.52亿美元。